Markets
COO

Inogen (INGN) Q1 Earnings: What's in Store for the Stock?

Inogen Inc.INGN is scheduled to report first-quarter 2016 results on May 9. Last quarter, the company reported earnings of 14 cents per share which beat the Zacks Consensus Estimate by 7 cents.

Notably, the company beat the Zacks Consensus Estimate in the last four consecutive quarters, with an average earnings surprise of 31.91%.

Want the latest recommendations from Zacks Investment Research?
Today, you can download

Let us see how things are shaping up for this announcement.

Factors Influencing This Quarter

We believe Inogen's unique direct-to-customer business model, innovative product portfolio and growing patient base will drive significant top-line growth. Expansion of the company's direct-to-consumer network and shift to cash sales of systems will boost margins. Meanwhile, new products like the upgraded Inogen One G3 and the upcoming Inogen One G4 are expected to drive growth further.

However, anticipated changes in Medicare reimbursements will hurt rental revenues going forward. Moreover, it has been proposed that Medicare patients should take prior authorization for stationary oxygen services. We believe that this will delay the process of issuing new systems on a rental basis, which will eventually hurt the top line.

Earnings Whispers

Our proven model does not conclusively show that Inogen is likely to beat earnings this quarter. That is because a stock needs to have both a positive Earnings ESP and a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold) for this to happen. That is not the case here as you will see below.

Zacks ESP : Inogen has a -8.33% ESP. This is because the Most Accurate estimate stands at 11 cents, while the Zacks Consensus Estimate is pegged at 12 cents.

Zacks Rank : Inogen carries a Zacks Rank #2, which increases the predictive power of ESP; but when combined with a -8.33% ESP, it makes surprise prediction difficult.

We caution against stocks with a Zacks Ranks #4 and 5 (Sell-rated stocks) going into the earnings announcement, especially when the company is seeing negative estimate revisions.

Stocks That Warrant a Look

Here are some health care stocks that you may want to consider, as our model shows that these have the right combination of elements to post an earnings beat this quarter.

Intrexon Corp. XON has an Earnings ESP of +17.39% and a Zacks Rank #1.

Quality Systems QSII has an Earnings ESP of +6.25% and a Zacks Rank #2.

The Cooper Companies COO has an Earnings ESP of +0.52% and a Zacks Rank #2.

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days.Click to get this free report >>

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

QUALITY SYS (QSII): Free Stock Analysis Report

INOGEN INC (INGN): Free Stock Analysis Report

COOPER COS (COO): Free Stock Analysis Report

INTREXON CORP (XON): Free Stock Analysis Report

To read this article on Zacks.com click here.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.


The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

In This Story

COO PGEN INGN

Other Topics

Earnings Stocks

Latest Markets Videos

Zacks

Zacks is the leading investment research firm focusing on stock research, analysis and recommendations. In 1978, our founder discovered the power of earnings estimate revisions to enable profitable investment decisions. Today, that discovery is still the heart of the Zacks Rank. A wealth of resources for individual investors is available at www.zacks.com.

Learn More